About
Our Mission: No One Should Face The Fight Alone.
Building Patient Centric Framework in Over 60 countries.
Meet Our Executive Board Members: https://www.fightcancerglobal.com/info/executiveboard/
Meet Our Global Leadership Members: https://www.fightcancerglobal.com/globalleadership
Corporate Headquarters: Houston,Texas
Good Day Fight Cancer Global Partners. 2019 is on the horizon. Challenges remain within our community but together we can make a difference. Our community is your community and this year Fight Cancer Global has strived to aggressively reach out in support of our vibrant, socially aware and technologically advanced community. Our goal at Fight Cancer Global it to maintain a self sustaining organization where you can access one of the largest global social networking multimedia platforms. We hope to streamline the flow of information to the 90 million in our community with the ultimate goal of empowering cancer patients and cultivating global collaborations. Your mission is our mission. We encourage you to partner with us by leveraging our platform and join us as we Come Together, Stand Together and Fight Together against Cancer.
Regards,
Moe Abdo, MD
Articles by Moe
-
Good Day Fight Cancer Global Partners,
Good Day Fight Cancer Global Partners,
In 2016 the global community of cancer patients, survivors and those in their support systems have endured many…
6 Comments -
Global problems require Global solutions
Global problems require Global solutions
The right partnerships yield the greatest results. In the scope of medicine and healthcare the key is uniting these…
1 Comment
Activity
-
Bacterial vaccine shows promise as cancer immunotherapy #innovation #medicine
Bacterial vaccine shows promise as cancer immunotherapy #innovation #medicine
Liked by Moe Abdo, MD
-
Farklı kanser türleri hakkında küresel veriler ve araştırmalar @OurWorldInData bölgeler ve ülkeler arasında mevcuttur. Kanser için risk faktörleri…
Farklı kanser türleri hakkında küresel veriler ve araştırmalar @OurWorldInData bölgeler ve ülkeler arasında mevcuttur. Kanser için risk faktörleri…
Liked by Moe Abdo, MD
-
ADCs represent one of the most rapidly expanding treatment modalities in oncology, with 11 ADCs FDA-approved & more than 210 currently being tested…
ADCs represent one of the most rapidly expanding treatment modalities in oncology, with 11 ADCs FDA-approved & more than 210 currently being tested…
Liked by Moe Abdo, MD
Experience
-
-
-
-
-
-
-
Education
-
-
UCI offers 87 undergraduate degree programs, as well as 59 master's; an M.D., Ed.D. and J.D.; and 46 Ph.D. programs.
The first public law school in California to open in more than 40 years, the UCI School of Law is ranked among the top 10 in the nation for its faculty's scholarly impact.
UCI's 162,000 graduates include leaders in the arts, sciences, business, education – all walks of life. Among them are three Pulitzer Prize winners and the architect of the "HTTP/1.1" Internet protocol…UCI offers 87 undergraduate degree programs, as well as 59 master's; an M.D., Ed.D. and J.D.; and 46 Ph.D. programs.
The first public law school in California to open in more than 40 years, the UCI School of Law is ranked among the top 10 in the nation for its faculty's scholarly impact.
UCI's 162,000 graduates include leaders in the arts, sciences, business, education – all walks of life. Among them are three Pulitzer Prize winners and the architect of the "HTTP/1.1" Internet protocol used worldwide.
The UCI Libraries, the region's largest information resource, draw more than half of their 2 million-plus annual visitors from outside the campus community.
More activity by Moe
-
#Immunotherapy | #ProstateCancer | #Sialoglycoproteins suppress Immune Cell #Killing by binding to to selective #Siglecs | #CD59: a targetable Siglec…
#Immunotherapy | #ProstateCancer | #Sialoglycoproteins suppress Immune Cell #Killing by binding to to selective #Siglecs | #CD59: a targetable Siglec…
Liked by Moe Abdo, MD
-
Antibody-Based Cancer Therapy: Bispecifics and Multispecifics 👉 Cancer therapy with antibodies https://lnkd.in/dUiP3buj (Nat Rev Cancer, Suman Paul…
Antibody-Based Cancer Therapy: Bispecifics and Multispecifics 👉 Cancer therapy with antibodies https://lnkd.in/dUiP3buj (Nat Rev Cancer, Suman Paul…
Liked by Moe Abdo, MD
-
𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧: How rADCs are Redefining Cancer Therapy 👇 Pharmaceutical companies are increasingly focusing on radiolabeled…
𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧: How rADCs are Redefining Cancer Therapy 👇 Pharmaceutical companies are increasingly focusing on radiolabeled…
Liked by Moe Abdo, MD
-
Feeling humbled and incredibly grateful for all the attention our article is receiving! Check out another fantastic highlight from Cancer Discovery.…
Feeling humbled and incredibly grateful for all the attention our article is receiving! Check out another fantastic highlight from Cancer Discovery.…
Liked by Moe Abdo, MD
-
Cancer immune evasion is a multifaceted process—tumors employ a mix of antigen hiding, immune cell reprogramming, & metabolic control to escape…
Cancer immune evasion is a multifaceted process—tumors employ a mix of antigen hiding, immune cell reprogramming, & metabolic control to escape…
Liked by Moe Abdo, MD
-
Glioblastoma is the most common and aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against…
Glioblastoma is the most common and aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against…
Liked by Moe Abdo, MD
-
Stanford Medicine researchers, after creating an AI-based algorithm to find complex structural variants in the human genome, learned those variants…
Stanford Medicine researchers, after creating an AI-based algorithm to find complex structural variants in the human genome, learned those variants…
Liked by Moe Abdo, MD
-
People receiving imatinib (Gleevec) as a treatment for some advanced gastrointestinal stromal tumors (GISTs) should continue the therapy without…
People receiving imatinib (Gleevec) as a treatment for some advanced gastrointestinal stromal tumors (GISTs) should continue the therapy without…
Liked by Moe Abdo, MD
-
Types, Features and Symptoms of Breast Cancer Florida’s Top Choice for Breast Cancer Treatment https://lnkd.in/eQMxUT8S Moffitt Cancer Center -…
Types, Features and Symptoms of Breast Cancer Florida’s Top Choice for Breast Cancer Treatment https://lnkd.in/eQMxUT8S Moffitt Cancer Center -…
Liked by Moe Abdo, MD
-
The FDA has approved a cellular therapy called afamitresgene autoleucel, or afami-cel (Tecelra), to treat some people with metastatic synovial…
The FDA has approved a cellular therapy called afamitresgene autoleucel, or afami-cel (Tecelra), to treat some people with metastatic synovial…
Liked by Moe Abdo, MD
-
Neoself-antigens are the primary target for autoreactive T cells in human lupus - Specific MHC-II alleles significantly impact the risk of…
Neoself-antigens are the primary target for autoreactive T cells in human lupus - Specific MHC-II alleles significantly impact the risk of…
Liked by Moe Abdo, MD
-
The muscle-brain connection: The role of exercise-induced myokines in combatting aging-delated disease(s) This post is meant to highlight how…
The muscle-brain connection: The role of exercise-induced myokines in combatting aging-delated disease(s) This post is meant to highlight how…
Liked by Moe Abdo, MD
-
Cancer itself can’t be passed down from parents to children. And genetic changes in tumor cells can’t be passed down. But a genetic change that…
Cancer itself can’t be passed down from parents to children. And genetic changes in tumor cells can’t be passed down. But a genetic change that…
Liked by Moe Abdo, MD
-
Can gut bacteria influence prostate health? New research says YES. A recent review, "The Role of Gut Microbiota in Prostate Inflammation and Benign…
Can gut bacteria influence prostate health? New research says YES. A recent review, "The Role of Gut Microbiota in Prostate Inflammation and Benign…
Liked by Moe Abdo, MD
-
AMERICAN SOCIETY OF CLINICAL ONCOLOGY KNOWLEDGE CONQUERS CANCER October 9, 2024 at 3.00pm-5.00pm GMT To Register: Click www.icedoc.website then…
AMERICAN SOCIETY OF CLINICAL ONCOLOGY KNOWLEDGE CONQUERS CANCER October 9, 2024 at 3.00pm-5.00pm GMT To Register: Click www.icedoc.website then…
Shared by Moe Abdo, MD
-
Researchers supported by NCI have developed an improved prostate cancer biomarker test that may help some men avoid an unnecessary biopsy…
Researchers supported by NCI have developed an improved prostate cancer biomarker test that may help some men avoid an unnecessary biopsy…
Liked by Moe Abdo, MD
Other similar profiles
Explore more posts
-
Sherif Kamal
📢 **Exciting Research Update!** We are thrilled to share the latest publication from our team in the Asian Pacific Journal of Cancer Prevention: **Title:** Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients **Authors:** Norhan Shalaby, Hala F Zaki, Osama A Badary, Sherif Kamal, Mohamed Nagy, Dalia Makhlouf, Amr Elnashar, Enas Elnady, Sameh A Abdelshafi, Sherif Abouelnaga, and Mona M Saber **Journal:** Asian Pac J Cancer Prev. 2024; 25(4): 1391–1409. **DOI:** 10.31557/APJCP.2024.25.4.1391 **PMCID:** PMC11162739 **PMID:** 38680001 🔍 **Abstract:** This study investigates the impact of CYP3A5 genetic polymorphisms on the efficacy and toxicity of Vincristine (VCR) in pediatric patients with Rhabdomyosarcoma (RMS) in Egypt. Key findings include the correlation between CYP3A5 genotypes and the incidence of VCR-induced neuropathy, highlighting the role of genetic factors in treatment outcomes. 📊 **Highlights:** - Patients with CYP3A5*3/*3 genotype exhibited the highest incidence of VCR-induced neuropathy (61.3%). - No significant correlation between CYP3A5 genotypes and RMS survival was observed. - This research underscores the importance of genetic profiling in personalized cancer treatment. Read the full study here and explore the comprehensive data on how genetic variations can influence treatment responses and side effects. **License:** This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. [Read more](https://lnkd.in/d5Cu8Nmn) #CancerResearch #PediatricOncology #Rhabdomyosarcoma #Vincristine #GeneticPolymorphism #PersonalizedMedicine #AsianPacJCancerPrev
-
David Lubarsky
Embracing the new era of gene editing at UC Davis Health and beyond. We provide assistance in developing gene knockout, gene silencing, or gene activation studies, and more. Our platform involves the use of Transcription Activator-like effectors and CRISPR guide-RNA to perform double stranded breaks of the DNA or epigenetic modifications. The tools of gene editing have given scientists the possibility to treat genetic diseases in ways that did not exist years earlier. Always innovating for patients! Interesting perspective below: https://lnkd.in/g2thrJ4G
1 Comment -
The Clinical Center of Excellence of Baylor Black Sea Foundation
#hepatitisC #accesstotreatment #earlydiagnosis #HepHIV #communityscreening #outreachscreening #communityrelations Since 2007, Baylor Black Sea Foundation provides accessible, free-of-charge screening for hepatitis B & C, HIV, and other sexually transmitted infections within its two screening centers in Constanța and by running outreach screening activities across Dobrogea region (Tulcea and Constanța Counties). The community screening and counseling is linked to the two main long-term medical and psycho-social care programs, for people living with chronic hepatitis and for people living with HIV/AIDS. The immediate linkage to care leads to mitigating the treatment costs, limitation of transmission and the improvement of community health. We made the outreach testing for organized groups highly accessible, by maintaining long-term community relations throughout Dobrogea, https://lnkd.in/dEc47FyY
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Moe Abdo, MD
2 others named Moe Abdo, MD are on LinkedIn
See others named Moe Abdo, MD